chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ATOGEPANT for Migraine.    Concurrent medical conditions included Migraine.   On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started ATOGEPANT (unknown route) at an unspecified dose once a day. On an unknown date, the patient experienced MIGRAINE (Migraine). At the time of the report, MIGRAINE (Migraine) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided. The patient had only one pill left of Qulipta (Atogepant), and patient was going to her HCP , o would be skipping one day of therapy.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Inappropriate schedule of product administration, Oral mucosal blistering
Clinical narrative: Flushed in face; Tired; Inappropriate schedule of vaccine administered; Large blister inside of mouth, "a huge bump above edge of upper teeth on top of jaw", huge blister that was pushed up and fluid filled sac; This spontaneous case was reported by a consumer and describes the occurrence of ORAL MUCOSAL BLISTERING (Large blister inside of mouth, "a huge bump above edge of upper teeth on top of jaw", huge blister that was pushed up and fluid filled sac), FLUSHING (Flushed in face), FATIGUE (Tired) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE on 01-Apr-2021 and PFIZER BIONTECH COVID-19 VACCINE on 22-Apr-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Allergy to molds.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, the patient experienced ORAL MUCOSAL BLISTERING (Large blister inside of mouth, "a huge bump above edge of upper teeth on top of jaw", huge blister that was pushed up and fluid filled sac) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced FLUSHING (Flushed in face) and FATIGUE (Tired). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL N) at an unspecified dose and frequency. On 01-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, ORAL MUCOSAL BLISTERING (Large blister inside of mouth, "a huge bump above edge of upper teeth on top of jaw", huge blister that was pushed up and fluid filled sac), FLUSHING (Flushed in face) and FATIGUE (Tired) outcome was unknown.            Patient stated that she gargled half peroxide and half water for blister burst treatment. Concomitant medications were not provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Slight SOB; General aches; fatIgue; Nausea; Headache; This spontaneous case was reported by a nurse and describes the occurrence of DYSPNOEA (Slight SOB), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (General aches) and FATIGUE (fatIgue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 025J20-2A) for COVID-19 vaccination.     Concurrent medical conditions included Shellfish allergy, Iodine allergy, Penicillin allergy (PCN), Sulfonamide allergy, Drug allergy (Compazine), Lung sarcoid (Prednisone, Advair, Albuteral, Nasonex. No recent changes in status of chronic condition.) since 15-Jun-2015 and Hypokalemia. Concomitant products included MOMETASONE FUROATE (NASONEX) from 15-Jun-2000 to an unknown date for Allergy, POTASSIUM from 01-Jun-1990 to an unknown date for Hypokalemia, CYANOCOBALAMIN (B12-VITAMIN) for Nutritional support, PREDNISONE from 15-Jun-2015 to an unknown date and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) from 01-Jun-2019 to an unknown date for Sarcoidosis.   On 11-Jan-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 08-Feb-2021 at 11:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, the patient experienced NAUSEA (Nausea) and HEADACHE (Headache). On 07-Dec-2021, the patient experienced DYSPNOEA (Slight SOB), MYALGIA (General aches) and FATIGUE (fatIgue). At the time of the report, DYSPNOEA (Slight SOB), NAUSEA (Nausea), HEADACHE (Headache), MYALGIA (General aches) and FATIGUE (fatIgue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was given Cocomitant B12  start date was given as 06/15/015. Patient's year of birth was on 1950.   This case was linked to MOD-2021-006006, MOD-2021-404883 (Patient Link).
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: after second dose, COVID arm reaction; red circle around the injection site; slightly itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (after second dose, COVID arm reaction), VACCINATION SITE ERYTHEMA (red circle around the injection site) and VACCINATION SITE PRURITUS (slightly itchy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 039A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-May-2021, the patient experienced VACCINATION SITE REACTION (after second dose, COVID arm reaction), VACCINATION SITE ERYTHEMA (red circle around the injection site) and VACCINATION SITE PRURITUS (slightly itchy). At the time of the report, VACCINATION SITE REACTION (after second dose, COVID arm reaction), VACCINATION SITE ERYTHEMA (red circle around the injection site) and VACCINATION SITE PRURITUS (slightly itchy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided. No treatment medications provided.   This case was linked to MOD-2021-406282 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache worse after booster dose,It was like a throb in the front of her head.; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache worse after booster dose,It was like a throb in the front of her head.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 017B21A and 020B21A) for COVID-19 vaccination.     The patient's past medical history included Headache and Migraine. Concurrent medical conditions included Blood pressure. Concomitant products included GABAPENTIN for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, the patient experienced HEADACHE (headache worse after booster dose,It was like a throb in the front of her head.). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and LIDOCAINE at an unspecified dose and frequency. At the time of the report, HEADACHE (headache worse after booster dose,It was like a throb in the front of her head.) was resolving.            Other concomitant medication included blood pressure medication.  Treatment medication included gabapentin.   This case was linked to MOD-2021-406267, MOD-2021-406269 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: achy legs from previous dose; She reports headache from her previous two doses; This spontaneous case was reported by a non-health professional and describes the occurrence of PAIN IN EXTREMITY (achy legs from previous dose) and HEADACHE (She reports headache from her previous two doses) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Migraine. Concurrent medical conditions included Hypertension. Concomitant products included GABAPENTIN for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (achy legs from previous dose) and HEADACHE (She reports headache from her previous two doses). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (achy legs from previous dose) and HEADACHE (She reports headache from her previous two doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication include Blood pressure medication.   This case was linked to MOD-2021-406263 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Achy legs from previous dose; Headache from her previous two doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achy legs from previous dose) and HEADACHE (Headache from her previous two doses) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Migraine and Headache. Concomitant products included GABAPENTIN for an unknown indication.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Achy legs from previous dose) and HEADACHE (Headache from her previous two doses). At the time of the report, PAIN IN EXTREMITY (Achy legs from previous dose) and HEADACHE (Headache from her previous two doses) outcome was unknown.      Concomitant medication also include blood pressure medication. No treatment information were given.   This case was linked to MOD-2021-406263 (Patient Link).
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dry mouth, Joint swelling, Vaccination site pain
Clinical narrative: swollen ankle with no pain; dry mouth; pain in the knee; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (swollen ankle with no pain), DRY MOUTH (dry mouth), ARTHRALGIA (pain in the knee) and VACCINATION SITE PAIN (soreness at injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Back surgery. Previously administered products included for Product used for unknown indication: Johnson&Johnson Vaccine on 09-Apr-2021. Past adverse reactions to the above products included No adverse event with Johnson&Johnson Vaccine. Concurrent medical conditions included Atrial fibrillation, Blood pressure high, Back disorder, Pancreatitis and Allergy to antibiotic (erythromycin allergy). Concomitant products included CARVEDILOL (COREG), PANCREATIN (CREON), FAMOTIDINE (PEPCID [FAMOTIDINE]), OLANZAPINE (ZYPREXA) and HYDROCODONE BITARTRATE, PARACETAMOL (NORCO) for an unknown indication.    On 06-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (swollen ankle with no pain), DRY MOUTH (dry mouth), ARTHRALGIA (pain in the knee) and VACCINATION SITE PAIN (soreness at injection site). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, JOINT SWELLING (swollen ankle with no pain), DRY MOUTH (dry mouth), ARTHRALGIA (pain in the knee) and VACCINATION SITE PAIN (soreness at injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: experienced no side effects other than the typical side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (experienced no side effects other than the typical side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION COMPLICATION (experienced no side effects other than the typical side effects). At the time of the report, VACCINATION COMPLICATION (experienced no side effects other than the typical side effects) outcome was unknown.            No concomitant medications provided. No treatment medications provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: sore arm for 6 months; after doses had fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for 6 months) and FATIGUE (after doses had fatigue) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Immunocompromised (has a bad immune system because of this). Concomitant products included ZINC, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), VITAMIN D [VITAMIN D NOS], ETANERCEPT (ENBREL), VITAMIN C [ASCORBIC ACID], MULTIVITAMIN [VITAMINS NOS], FLUOXETINE HYDROCHLORIDE (PROZAC) and PREDNISONE for an unknown indication.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm for 6 months) and FATIGUE (after doses had fatigue). At the time of the report, PAIN IN EXTREMITY (sore arm for 6 months) and FATIGUE (after doses had fatigue) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient reported after both doses, had fatigue and sore arm for 6 months.   Patient did not take any treatment.   This case was linked to MOD-2021-406307 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Booster dose was 1ml; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Booster dose was 1ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced ACCIDENTAL OVERDOSE (Booster dose was 1ml). In August 2021, ACCIDENTAL OVERDOSE (Booster dose was 1ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain on both of his arms in the deltoid muscles; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain on both of his arms in the deltoid muscles) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain on both of his arms in the deltoid muscles). At the time of the report, VACCINATION SITE PAIN (pain on both of his arms in the deltoid muscles) had not resolved.            No concomitant medication was provided. No treatment medication was provided. Patient reported that he had the 2 shots of the Moderna vaccine and wants to find a place where he can have the booster dose done on his thigh or rear.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Pyrexia
Clinical narrative: Felt like had the flu; Chills; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Dec-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, INFLUENZA LIKE ILLNESS (Felt like had the flu), CHILLS (Chills), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.            No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-406396 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal, Headache
Clinical narrative: a little dizzy after the second dose; not feeling myself after the second dose; Feeling very weak after the second dose; terrific headache after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (a little dizzy after the second dose), FEELING ABNORMAL (not feeling myself after the second dose), ASTHENIA (Feeling very weak after the second dose) and HEADACHE (terrific headache after the second dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004121A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation, Heart disease, unspecified and Thyroid disorder NOS. Concomitant products included CLINDAMYCIN PHOSPHATE (DIVANON) for Blood pressure, METOPROLOL for Heart disease, unspecified, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder NOS.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2021, the patient experienced DIZZINESS (a little dizzy after the second dose), FEELING ABNORMAL (not feeling myself after the second dose), ASTHENIA (Feeling very weak after the second dose) and HEADACHE (terrific headache after the second dose). On 19-May-2021, DIZZINESS (a little dizzy after the second dose), FEELING ABNORMAL (not feeling myself after the second dose), ASTHENIA (Feeling very weak after the second dose) and HEADACHE (terrific headache after the second dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-406393 (Patient Link).
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: She also got a fever yesterday; She is a little sore/Her arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She is a little sore/Her arm is sore) and PYREXIA (She also got a fever yesterday) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced PAIN IN EXTREMITY (She is a little sore/Her arm is sore). On 07-Dec-2021, the patient experienced PYREXIA (She also got a fever yesterday). At the time of the report, PAIN IN EXTREMITY (She is a little sore/Her arm is sore) and PYREXIA (She also got a fever yesterday) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant and Treatment medication were reported.
Sex: U
Vaccine: COVID19
Symptoms: Amnesia
Clinical narrative: temporary memory loss; This spontaneous case was reported by an other health care professional and describes the occurrence of AMNESIA (temporary memory loss) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AMNESIA (temporary memory loss). At the time of the report, AMNESIA (temporary memory loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Headache, Nausea
Clinical narrative: Stomach ache; Dizziness; Nausea; a ready bad headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach ache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEADACHE (a ready bad headache) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder NOS.   On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Dec-2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach ache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEADACHE (a ready bad headache). At the time of the report, ABDOMINAL PAIN UPPER (Stomach ache), DIZZINESS (Dizziness), NAUSEA (Nausea) and HEADACHE (a ready bad headache) had resolved.            No treatment medication received for events. Patient experienced all events for a couple of days. Patient under several cardiac medications. This symptoms were present after second vaccination 28Jan2021. Unspecified cardiac medications include blood presure med lvarcy rosuvasthm, omeprazol and buspirine. fluxatin simbucord adderal.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fever; Real tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and FATIGUE (Real tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21 and 013M207) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever) and FATIGUE (Real tired). At the time of the report, PYREXIA (Fever) and FATIGUE (Real tired) outcome was unknown.            No concomitant medications were reported   No treatment information was provided   This case was linked to MOD-2021-406401 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: arm swelled up after dose 1; arm was red after dose 1; arm itched after dose 1; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm swelled up after dose 1), ERYTHEMA (arm was red after dose 1) and PRURITUS (arm itched after dose 1) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Thyroid disorder. Concomitant products included ALPRAZOLAM (XANAX) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm swelled up after dose 1), ERYTHEMA (arm was red after dose 1) and PRURITUS (arm itched after dose 1). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (arm swelled up after dose 1), ERYTHEMA (arm was red after dose 1) and PRURITUS (arm itched after dose 1) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication includes: Medication for Blood pressure, Medication for Thyroid and water pill once in a while   This case was linked to MOD-2021-406413 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Aching joints/she had knee joint pain/she had hip joint pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Aching joints/she had knee joint pain/she had hip joint pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021H21B and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Aching joints/she had knee joint pain/she had hip joint pain). At the time of the report, ARTHRALGIA (Aching joints/she had knee joint pain/she had hip joint pain) outcome was unknown.            No concomitant medications was reported.  No treatment drug details was reported.   This case was linked to MOD-2021-406400, MOD-2021-406408 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Late long lasting reaction; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Late long lasting reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.    In April 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Late long lasting reaction). At the time of the report, VACCINATION COMPLICATION (Late long lasting reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant information was reported. No Treatment information was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pyrexia
Clinical narrative: She also has a sore arm; has now ran a fever of 100.1°F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She also has a sore arm) and PYREXIA (has now ran a fever of 100.1°F) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 064H21A, 013L20A and CB2CA) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Thyroid disorder NOS. Concomitant products included ALPRAZOLAM (XANAX) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced PAIN IN EXTREMITY (She also has a sore arm) and PYREXIA (has now ran a fever of 100.1°F). At the time of the report, PAIN IN EXTREMITY (She also has a sore arm) and PYREXIA (has now ran a fever of 100.1°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Dec-2021, Body temperature: 100.1 (High) 100.1 F.         Concomitants Included medication for blood pressure, medication for thyroid, Water pill (once in a while).  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-406406 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness
Clinical narrative: dizzy; chills; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (dizzy) and CHILLS (chills) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy) and CHILLS (chills). At the time of the report, DIZZINESS (dizzy) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: administered booster dose 26 days early; This spontaneous case was reported by another health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered booster dose 26 days early) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered booster dose 26 days early). On 30-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (administered booster dose 26 days early) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. She declined that the patient experienced any side effects or symptoms that she is aware of.   Reporter did not allow further contact
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased
Clinical narrative: Fast heart rate (120 BPM); This spontaneous case was reported by a pharmacist and describes the occurrence of HEART RATE INCREASED (Fast heart rate (120 BPM)) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced HEART RATE INCREASED (Fast heart rate (120 BPM)). At the time of the report, HEART RATE INCREASED (Fast heart rate (120 BPM)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Dec-2021, Heart rate: 120 bpm (High) Fast Heart rate.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   As mentioned by the reporter the patient was not exercising along with Lot, Expiration Dates and primary series injections dates as unknown. No concomitant medications were mentioned. No treatment details were reported.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Discomfort, Gait disturbance, Insomnia, Myalgia
Clinical narrative: Hard time getting out of the bed; Hard time walking; Hard time to sleep; Intense body aches; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Hard time getting out of the bed), GAIT DISTURBANCE (Hard time walking), INSOMNIA (Hard time to sleep), MYALGIA (Intense body aches) and ARTHRALGIA (Joint pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H216, 026A21A and 026M21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Blood pressure high.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Hard time getting out of the bed), GAIT DISTURBANCE (Hard time walking), INSOMNIA (Hard time to sleep), MYALGIA (Intense body aches) and ARTHRALGIA (Joint pain). At the time of the report, DISCOMFORT (Hard time getting out of the bed), GAIT DISTURBANCE (Hard time walking), INSOMNIA (Hard time to sleep), MYALGIA (Intense body aches) and ARTHRALGIA (Joint pain) was resolving.            No Concomitant product use was reported. No treatment information was provided.  The reporter was reporting adverse event on the behalf of themselves and their husband who was the patient. The patient after getting the booster started to experience intense body aches, joint pain, hard time getting out of the bed, hard time walking and hard time to sleep. The reporter stated that overall symptoms were improving. The reporter also reported elevated liver enzymes.   This case was linked to MOD-2021-406429 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: bad side effects from both of my doses/awfully to both dose; This spontaneous case was reported by another health care professional and describes the occurrence of VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose). At the time of the report, VACCINATION COMPLICATION (bad side effects from both of my doses/awfully to both dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication use was reported.   This case was linked to MOD-2021-406474 (Patient Link).   Reporter did not allow further contact
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 1st dose of moderna vaccine given to a 14 year old/ A moderna covid-19 vaccine was administered to an individual under the age of 18; This spontaneous case was reported by another health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of moderna vaccine given to a 14 year old/ A moderna covid-19 vaccine was administered to an individual under the age of 18) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of moderna vaccine given to a 14 year old/ A moderna covid-19 vaccine was administered to an individual under the age of 18). On 11-Nov-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of moderna vaccine given to a 14 year old/ A moderna covid-19 vaccine was administered to an individual under the age of 18) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling
Clinical narrative: Persistent to the point that they became swollen; Rash all over her body - arms, legs, chest and back; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Persistent to the point that they became swollen) and RASH (Rash all over her body - arms, legs, chest and back) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021 at 1:30 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Nov-2021, the patient experienced SWELLING (Persistent to the point that they became swollen) and RASH (Rash all over her body - arms, legs, chest and back). On 03-Dec-2021, SWELLING (Persistent to the point that they became swollen) and RASH (Rash all over her body - arms, legs, chest and back) had resolved.            Concomitant product use was not provided by the reporter.  Treatment medications include steroids.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patients received expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired doses) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter. No treatment was provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: Urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Urinary tract infection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (Urinary tract infection). At the time of the report, URINARY TRACT INFECTION (Urinary tract infection) outcome was unknown.            Concomitant medications were not provided. Patient stated that at the moment of she was experiencing an urinary tract infection. Treatment information included Antibiotics.
Sex: U
Vaccine: COVID19
Symptoms: Product administration error
Clinical narrative: Extracted 22 booster doses from a Moderna Covid-19 vaccine vial and gave them to 19 patients; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Extracted 22 booster doses from a Moderna Covid-19 vaccine vial and gave them to 19 patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Dec-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Extracted 22 booster doses from a Moderna Covid-19 vaccine vial and gave them to 19 patients). On 08-Dec-2021, PRODUCT ADMINISTRATION ERROR (Extracted 22 booster doses from a Moderna Covid-19 vaccine vial and gave them to 19 patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter who was a nurse reported that they extracted 22 booster doses from a Moderna Covid-19 vaccine vial and gave them to 19 patients on 08-Dec-2021. It was also reported that the vial did not undergo any temperature excursion prior and did not know if the last 2 extracted doses were administered to patients.  No Concomitant product use was reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: a little bit of fatigue after first dose; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (a little bit of fatigue after first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (she is usually allergic to everything).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (a little bit of fatigue after first dose). At the time of the report, FATIGUE (a little bit of fatigue after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that  the Moderna COVID-19 vaccine is "safe" because she is usually allergic to everything . No concomitant medications were reported   No treatment information was provided   This case was linked to MOD-2021-406505 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: problems with her legs; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (problems with her legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (problems with her legs). At the time of the report, LIMB DISCOMFORT (problems with her legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the friend did not have diabetes. No concomitant product was provided by the reporter. No treatment medication was provided.   This case was linked to MOD-2021-403137 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: possibly receiving expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (possibly receiving expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037f21a) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (possibly receiving expired vaccine). In November 2021, EXPIRED PRODUCT ADMINISTERED (possibly receiving expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medication was reported.     No treatment medications were reported.   This case was linked to MOD-2021-406416 (Patient Link).